Multi-Channel, Pre-Approval, and Non-Promotional Communication
A session from FDLI’s Introduction to Advertising and Promotion for Medical Products
Recorded September 30, 2025
Multi-Channel, Pre-Approval, and Non-Promotional Communication, an Introduction to Medical Product Advertising and Promotion
- Types of Communication
- Defining and Distinguishing Promotional Content from Scientific Exchange
- Accepted Pre-approval Promotion—Coming Soon, Institutional
- Help-Seeking Advertisements—Disease Awareness
- First Amendment
- Digital Advertising and New Technologies
- Social Media Advertising
- Data Privacy
Heather Banuelos, Counsel, King & Spalding LLP
This session was recorded as part of FDLI’s Introduction to Advertising and Promotion for Medical Products Course in September 2025.
HEATHER BANUELOS is counsel in King & Spalding’s Washington, DC office and a member of the firm’s FDA & Life Sciences practice group. Her primary practice is focused on regulatory strategies and initiatives for the labeling, promotion and advertising of FDA-regulated products. She has served on over 20 different promotional review committees and medical and scientific review committees, with a knack for practical advice and recommendations to help clients find a path forward. Ms. Bañuelos’ experience in FDA law spans 19 years and includes positions as a former Associate Chief Counsel in the FDA’s Office of the Chief Counsel and senior in-house regulatory counsel for multiple clients, including two large pharmaceutical companies and a leading food company. Her experience in government and in-house give her a unique and valuable perspective as outside counsel.Get Access
$149
-
+$100 for nonmembers
Virtual Learning FAQ
Related Content
